What are the best treatments for Von Willebrand Disease?

The primary goal of Von Willebrand Disease (VWD) treatment is to increase levels of von Willebrand factor (VWF) and Factor VIII in the blood to prevent or stop bleeding episodes. Treatment is highly personalized based on the specific type and severity of Von Willebrand Disease, typically involving medications like desmopressin or VWF replacement therapies to manage clotting function.

What are the first-line medical treatments for Von Willebrand Disease?

Treatment for Von Willebrand Disease is tailored to the patient’s specific VWD subtype (Type 1, 2, or 3). The most common first-line therapy is desmopressin (DDAVP, Stimate), a synthetic hormone that stimulates the release of stored VWF from the body’s tissues into the bloodstream. For patients who do not respond to desmopressin, or for those with more severe forms of the condition, physicians prescribe factor replacement therapy. These therapies involve intravenous infusions of concentrated VWF and Factor VIII derived from human plasma (such as Humate-P or Wilate) or, in some cases, recombinant (genetically engineered) VWF (Vonvendi).

What non-pharmacological management strategies are used?

Beyond medication, managing Von Willebrand Disease requires lifestyle modifications to minimize the risk of trauma and uncontrolled bleeding. Patients are often advised to avoid medications that interfere with platelet function, such as aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs (NSAIDs). Additional management strategies include:

• Dental Care: Maintaining rigorous oral hygiene to prevent gum disease and the need for invasive dental procedures.


• Activity Modification: Choosing non-contact sports over high-impact activities to reduce the risk of internal or external injury.


• Surgical Planning: Coordinating with a hematologist before any surgery or tooth extraction to ensure VWF levels are adequate to prevent excessive perioperative bleeding.


• Genetic Counseling: Understanding the inheritance pattern—which is typically autosomal dominant for Type 1 and 2, and autosomal recessive for Type 3—to inform family planning.

What specialists should be on the care team for Von Willebrand Disease?

Because Von Willebrand Disease can affect various systems in the body, a multidisciplinary approach is essential for comprehensive care. Patients should ideally be managed at a Hemophilia Treatment Center (HTC) or by a team that includes:

• Hematologist: The lead specialist who monitors factor levels and manages long-term treatment protocols.


• Genetic Counselor: To help interpret inheritance risks and provide support to families.


• Gynecologist: Essential for women with Von Willebrand Disease to manage heavy menstrual bleeding (menorrhagia) and pregnancy-related complications.


• Clinical Psychologist: To provide support for the emotional impact of living with a chronic, lifelong bleeding disorder.

How does treatment effectiveness vary between patients?

Effectiveness varies significantly depending on the subtype of Von Willebrand Disease. Patients with Type 1 may only need treatment during surgery or injury, while those with Type 3—the most severe form—require regular prophylactic infusions to prevent spontaneous bleeding. The 184 members of our DiseaseMaps.org community often share that finding the "right" treatment is a process of trial and error, requiring close communication with a hematologist to monitor how the body responds to specific therapies over time.

What is the future outlook for treatment?

Clinical research is actively exploring new ways to treat Von Willebrand Disease. Current areas of interest include longer-acting recombinant factor products that require fewer infusions and gene therapy research aimed at correcting the underlying genetic mutation. Patients are encouraged to discuss ongoing clinical trials with their medical team to see if they are candidates for emerging therapies.

Next steps

• Consult a hematologist specializing in bleeding disorders to confirm your specific VWD subtype.


• Maintain a "bleeding diary" to track episodes, which helps your physician adjust your treatment plan.


• Join the Von Willebrand Disease community on DiseaseMaps.org to connect with others who share your lived experience.


• Wear a medical alert bracelet to ensure emergency responders are aware of your diagnosis.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your hematologist or healthcare provider to develop a treatment plan personalized to your specific medical needs.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): Von Willebrand Disease.


• Orphanet: Von Willebrand Disease (ORPHA:900).


• National Hemophilia Foundation (NHF): Medical and Scientific Advisory Council (MASAC) Guidelines.


• OMIM (Online Mendelian Inheritance in Man): Entry #193400 (Von Willebrand Disease).